This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martinand, C.
Right arrow Articles by Bisbal, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martinand, C.
Right arrow Articles by Bisbal, C.

 Previous Article  |  Next Article 

Journal of Virology, January 1999, p. 290-296, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

RNase L Inhibitor Is Induced during Human Immunodeficiency Virus Type 1 Infection and Down Regulates the 2-5A/RNase L Pathway in Human T Cells

Camille Martinand, Céline Montavon,dagger Tamim Salehzada, Michelle Silhol, Bernard Lebleu, and Catherine Bisbal*

Institut de Génétique Moléculaire de Montpellier (UMR 5535, CNRS-Université de Montpellier II), 34293 Montpellier Cedex 5, France

Received 26 June 1998/Accepted 22 September 1998

The interferon-regulated 2-5A/RNase L pathway plays a major role in the antiviral and antiproliferative activities of these cytokines. Several viruses, however, have evolved strategies to escape the antiviral activity of the 2-5A/RNase L pathway. In this context, we have cloned a cDNA coding for the RNase L inhibitor (RLI), a protein that specifically inhibits RNase L and whose regulated expression in picornavirus-infected cells down regulates the activity of the 2-5A/RNase L pathway. We show here that RLI increases during the course of human immunodeficiency virus type 1 (HIV-1) infection, which may be related to the downregulation of RNase L activity that has been described to occur in HIV-infected cells. In order to establish a possible causal relationship between these observations, we have stably transfected H9 cells with RLI sense or antisense cDNA-expressing vectors. The overexpression of RLI causes a decrease in RNase L activity and a twofold enhancement of HIV production. This increase in HIV replication correlates with an increase in HIV RNA and proteins. In contrast, reduction of RLI levels in RLI antisense cDNA-expressing clones reverses the inhibition of RNase L activity associated with HIV multiplication and leads to a threefold decrease in the viral load. This anti-HIV activity correlated with a decrease in HIV RNA and proteins. These findings demonstrate that the level of RLI, via its modulation of RNase L activity, can severely impair HIV replication and suggest the involvement of RLI in the inhibition of the 2-5A/RNase L system observed during HIV infection.


* Corresponding author. Mailing address: Institut de Genetique Moleculaire de Montpellier, UMR 5535, CNRS-Université de Montpellier II, 1919, route de Mende, 34293 Montpellier Cedex 5, France. Phone: 33-4-67-61-36-58. Fax: 33-4-67-04-02-45. E-mail: bisbal{at}jones.igm.cnrs-mop.fr.

dagger Present address: Laboratoire Retrovirus, ORSTOM, 34032 Montpellier Cedex 1, France.


Journal of Virology, January 1999, p. 290-296, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O., Mammano, F. (2009). Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer. J. Virol. 83: 10527-10537 [Abstract] [Full Text]  
  • Randall, R. E., Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89: 1-47 [Abstract] [Full Text]  
  • Silverman, R. H. (2007). Viral Encounters with 2',5'-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response. J. Virol. 81: 12720-12729 [Full Text]  
  • Andersen, D. S., Leevers, S. J. (2007). The Essential Drosophila ATP-binding Cassette Domain Protein, Pixie, Binds the 40 S Ribosome in an ATP-dependent Manner and Is Required for Translation Initiation. J. Biol. Chem. 282: 14752-14760 [Abstract] [Full Text]  
  • Ye, Y., Hauns, K., Langland, J. O., Jacobs, B. L., Hogue, B. G. (2007). Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist. J. Virol. 81: 2554-2563 [Abstract] [Full Text]  
  • Molinaro, R. J., Jha, B. K., Malathi, K., Varambally, S., Chinnaiyan, A. M., Silverman, R. H. (2006). Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res 34: 6684-6695 [Abstract] [Full Text]  
  • Hosmalin, A., Lebon, P. (2006). Type I interferon production in HIV-infected patients. J. Leukoc. Biol. 80: 984-993 [Abstract] [Full Text]  
  • Chen, Z.-q., Dong, J., Ishimura, A., Daar, I., Hinnebusch, A. G., Dean, M. (2006). The Essential Vertebrate ABCE1 Protein Interacts with Eukaryotic Initiation Factors. J. Biol. Chem. 281: 7452-7457 [Abstract] [Full Text]  
  • Lingappa, J. R., Dooher, J. E., Newman, M. A., Kiser, P. K., Klein, K. C. (2006). Basic Residues in the Nucleocapsid Domain of Gag Are Required for Interaction of HIV-1 Gag with ABCE1 (HP68), a Cellular Protein Important for HIV-1 Capsid Assembly. J. Biol. Chem. 281: 3773-3784 [Abstract] [Full Text]  
  • Sobol, P. T., Mossman, K. L. (2006). ICP0 Prevents RNase L-Independent rRNA Cleavage in Herpes Simplex Virus Type 1-Infected Cells. J. Virol. 80: 218-225 [Abstract] [Full Text]  
  • Espert, L., Degols, G., Lin, Y.-L., Vincent, T., Benkirane, M., Mechti, N. (2005). Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol. 86: 2221-2229 [Abstract] [Full Text]  
  • Dooher, J. E., Lingappa, J. R. (2004). Conservation of a Stepwise, Energy-Sensitive Pathway Involving HP68 for Assembly of Primate Lentivirus Capsids in Cells. J. Virol. 78: 1645-1656 [Abstract] [Full Text]  
  • Takedatsu, H., Shichijo, S., Katagiri, K., Sawamizu, H., Sata, M., Itoh, K. (2004). Identification of Peptide Vaccine Candidates Sharing among HLA-A3+, -A11+, -A31+, and -A33+ Cancer Patients. Clin. Cancer Res. 10: 1112-1120 [Abstract] [Full Text]  
  • Rogez, C., Martin, M., Dereuddre-Bosquet, N., Martal, J., Dormont, D., Clayette, P. (2003). Anti-Human Immunodeficiency Virus Activity of Tau Interferon in Human Macrophages: Involvement of Cellular Factors and {beta}-Chemokines. J. Virol. 77: 12914-12920 [Abstract] [Full Text]  
  • Smith, T. J., Silverman, R. H., Leib, D. A. (2003). RNase L activity does not contribute to host RNA degradation induced by herpes simplex virus infection. J. Gen. Virol. 84: 925-928 [Abstract] [Full Text]  
  • Behera, A. K., Kumar, M., Lockey, R. F., Mohapatra, S. S. (2002). 2'-5' Oligoadenylate Synthetase Plays a Critical Role in Interferon-gamma Inhibition of Respiratory Syncytial Virus Infection of Human Epithelial Cells. J. Biol. Chem. 277: 25601-25608 [Abstract] [Full Text]  
  • Le Roy, F., Bisbal, C., Silhol, M., Martinand, C., Lebleu, B., Salehzada, T. (2001). The 2-5A/RNase L/RNase L Inhibitor (RNI) Pathway Regulates Mitochondrial mRNAs Stability in Interferon alpha -treated H9 Cells. J. Biol. Chem. 276: 48473-48482 [Abstract] [Full Text]  
  • Zheng, X., Silverman, R. H., Zhou, A., Goto, T., Kwon, B. S., Kaufman, H. E., Hill, J. M. (2001). Increased Severity of HSV-1 Keratitis and Mortality in Mice Lacking the 2-5A-dependent RNase L Gene. IOVS 42: 120-126 [Abstract] [Full Text]  
  • Goodbourn, S., Didcock, L., Randall, R. E. (2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 81: 2341-2364 [Full Text]  
  • Bisbal, C., Silhol, M., Laubenthal, H., Kaluza, T., Carnac, G., Milligan, L., Le Roy, F., Salehzada, T. (2000). The 2'-5' Oligoadenylate/RNase L/RNase L Inhibitor Pathway Regulates Both MyoD mRNA Stability and Muscle Cell Differentiation. Mol. Cell. Biol. 20: 4959-4969 [Abstract] [Full Text]